ArticleCase reports in oncology

Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin.

Tatsuro Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.